NCT07000539View on ClinicalTrials.gov

Indocyanine Green Fluorescence Angiography (ICG-FA) in Revisional Bariatric Surgery

NARecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 6, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

February 28, 2026

Conditions
ObesityBariatric Surgery
Interventions
DIAGNOSTIC_TEST

Indocyanine Green Angiogram

Three different doses of indocyanin green will be compared (5 mg, 7.5 mg, and 10 mg). These doses are within the range of currently recommended doses by the International Society for Fluorescence Guided Surgery (ISFGS) for bariatric surgery.

Trial Locations (1)

22046

RECRUITING

Centro Medico Bariatrico, Tijuana

Sponsors

Collaborators (1)

Bariatric Medical Center
All Listed Sponsors
collaborator

Bariatric Medical Center

UNKNOWN

lead

Instituto Mexicano del Seguro Social

OTHER_GOV

NCT07000539 - Indocyanine Green Fluorescence Angiography (ICG-FA) in Revisional Bariatric Surgery | Biotech Hunter | Biotech Hunter